3rd Quarter - Report

AMERICAN SOCIETY FOR RADIATION ONCOLOGY for AMERICAN SOCIETY FOR RADIATION ONCOLOGY

Firm
Client
Income
—
Expenses
$188,191
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FY2024 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride Support for NRC Commissioner nominee to have medical background Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative Legislation to increase transparency in the prior authorization process Efforts to educate legislators about unintended consequences associated with rate setting for health care services Preserve current training and experience requirements for radiopharmaceuticals Support for advancing health equity and eliminating health care disparities Support current NRC medical event reporting regulations and patient safety protocols without additional requirements for extravasations Support for H.R. 8412, a bill to remove barriers to accessing clinical trials for underrepresented populations

LobbyistCovered position, as disclosed
DAVID ADLER —
ZACHARY CONNOR HARRIS New —
ANNE HUBBARD —
CYNTHIA TOMLINSON —
COURTNEY WILLIAMS —

Contacted: Food & Drug Administration (FDA); Nuclear Regulatory Commission (NRC); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: H.R. 8412 (118th)

Medicare/Medicaid MMM

Oppose restrictive prior authorization practices Support for structural changes that lead to delivering high quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value Support for waiving budget neutrality adjustments with evaluation and management code changes Support for protecting access to care for Medicare patients Oppose physician fee schedule cuts due to clinical labor price updates by supporting H.R. 3674 to provide relief and stability in Medicare payments Support for H.R. 1202 for resident education deferred interest Support for H.R. 2474 to add inflationary updates to the MPFS Support for H.R. 2761 to defer loan payments for specialty physicians in rural areas Support for H.R. 6683, to fix the Medicare Physician Fee Schedule physician payment reimbursement cut Support for H.R. 6800, a bill to increase pay cap for therapeutic medical physicists of the Department of Veterans Affairs Support for H.R. 8404 and S. 4330, a bill to modernize radiation oncology reimbursement - The Radiation Oncology Case Rate Value-Based Program Act of 2024

LobbyistCovered position, as disclosed
DAVID ADLER —
ZACHARY CONNOR HARRIS New —
ANNE HUBBARD —
CYNTHIA TOMLINSON —
COURTNEY WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 6800 (118th), H.R. 1202 (118th), H.R. 6683 (118th), H.R. 2474 (118th), H.R. 8404 (118th), S. 4330 (118th), H.R. 3674 (118th), H.R. 2761 (118th)

Homeland Security HOM

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery Support access to radioactive isotopes

LobbyistCovered position, as disclosed
DAVID ADLER —
ZACHARY CONNOR HARRIS New —
ANNE HUBBARD —
CYNTHIA TOMLINSON —
COURTNEY WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Nuclear Regulatory Commission (NRC)

Budget/Appropriations BUD

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal years 2024 and 2025 Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved Cancer Moonshot Initiative Support for ARPA-H to support innovative cancer treatments Support for initiatives to increase diversity in clinical trials Support for DOD lung cancer research program funding

LobbyistCovered position, as disclosed
DAVID ADLER —
ZACHARY CONNOR HARRIS New —
ANNE HUBBARD —
CYNTHIA TOMLINSON —
COURTNEY WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.